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Phosphorylation by casein kinase II at three specific residues (S-60, T-62, and S-64) within the acidic domain
I of the P protein of Indiana serotype vesicular stomatitis virus has been shown to be critical for in vitro
transcription activity of the viral RNA polymerase (P-L) complex. To examine the role of phosphorylation of
P protein in transcription as well as replication in vivo, we used a panel of mutant P proteins in which the
phosphate acceptor sites in domain I were substituted with alanines or other amino acids. Analyses of the
alanine-substituted mutant P proteins for the ability to support defective interfering RNA replication in vivo
suggest that phosphorylation of these residues does not play a significant role in the replicative function of the
P protein since these mutant P proteins supported replication at levels >70% of the wild-type P-protein level.
However, the transcription function of most of the mutant proteins in vivo was severely impaired (2 to 10% of
the wild-type P-protein level). The level of transcription supported by the mutant P protein (P60/62/64) in which
all phosphate acceptor sites have been mutated to alanines was at best 2 to 3% of that of the wild-type P protein.
Increasing the amount of P60/62/64 expression in transfected cells did not rescue significant levels of transcription. Substitution with other amino acids at these sites had various effects on replication and transcription.
While substitution with threonine residues (PTTT) had no apparent effect on transcription (113% of the
wild-type level) or replication (81% of the wild-type level), substitution with phenylalanine (PFFF) rendered the
protein much less active in transcription (<5%). Substitution with arginine residues led to significantly
reduced activity in replication (6%), whereas glutamic acid substituted P protein (PEEE) supported replication
(42%) and transcription (86%) well. In addition, the mutant P proteins that were defective in replication
(PRRR) or transcription (P60/62/64) did not behave as transdominant repressors of replication or transcription
when coexpressed with wild-type P protein. From these results, we conclude that phosphorylation of domain I
residues plays a major role in in vivo transcription activity of the P protein, whereas in vivo replicative function
of the protein does not require phosphorylation. These findings support the contention that different phosphorylated states of the P protein regulate the transcriptase and replicase functions of the polymerase protein, L.
21, 44). While the L protein carries the catalytic center for
polymerization of nucleotides during RNA synthesis, the P
protein serves as an accessory protein that is required for the
function of the L protein (1, 2). The P protein is multifunctional, playing key roles in both transcription and replication
processes. It interacts with the N protein, maintaining the N
protein in a form competent to support efficient RNA encapsidation during replication (47, 48, 54). It interacts with the L
protein and stabilizes the protein from proteolytic degradation
(9, 22). Furthermore, it interacts with specific nucleotide sequences at the termini of VSV genome, presumably for transcription and replication (29, 31). The P protein is found in
different phosphorylated forms in infected cells as well as in
the virion core, and different functional forms of P protein with
different degrees of phosphorylation have been shown to exist
(7, 14, 27, 28, 32, 41). A direct role of phosphorylation in
P-protein function was provided by the studies of Chattopadhyaya and Banerjee (12), who demonstrated that phosphorylation within a specific domain regulates the function of
P protein in transcription in vitro.
In the last few years, the role of phosphorylation of P protein
in transcription has been the subject of intense investigation.
Most of these studies were facilitated by the initial demonstration that expression of P protein of VSV New Jersey serotype
in bacteria yields a completely unphosphorylated P protein (P0

Vesicular stomatitis virus (VSV) is a negative-strand RNA
virus that carries an active RNA-dependent RNA polymerase
within the virion core. The nucleocapsid template in the virion
core consists of the 11,161-nucleotide (nt)-long genomic RNA
tightly wrapped around by the nucleocapsid protein (N) and is
the template for two distinct types of RNA synthetic processes
(transcription and replication) by the associated viral polymerase (1, 2, 20). In infected cells, the nucleocapsid core first
directs transcription to generate subgenomic mRNAs, which
are translated to produce viral proteins required for replication. During replication, a full-length complement (called antigenome) of the genomic RNA is synthesized in the form of a
nucleocapsid, which in turn acts as the template for the synthesis of genomic nucleocapsids. It is generally believed that
the same polymerase performs both transcriptive and replicative functions of the virus.
The RNA polymerase of VSV is a complex of two proteins:
the large protein, L, and the phosphoprotein, P. Several genetic and biochemical analyses have suggested that both proteins are required for the polymerase activity of the virus (18,
* Corresponding author. Mailing address: Department of Microbiology and Immunology, University of Miami School of Medicine, P.O.
Box 016960 (R-138), Miami, FL 33101. Phone: (305) 243-6711. Fax:
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The phosphorylation of these residues has been shown to be
important for activation of transcription in vitro by the P protein of New Jersey serotype (12). However, studies with Indiana serotype P protein indicate that phosphorylation of domain II residues may not have a role in transcription in vitro
(24, 40).
To address the role of phosphorylation within domain I of
the P protein of VSV (Indiana serotype) in RNA transcription
and replication in vivo, we have studied a panel of mutant P
proteins containing single, double, or triple alanine or other
amino acid substitutions at the three phosphate acceptor sites
(S-60, T-62, and S-64) within amino-terminal acidic domain I.
Our results show that while replication of defective interfering
(DI) RNA in vivo remained largely unaffected by the phosphorylation status of the P protein, transcription activity of the
mutant P proteins was significantly downregulated, indicating
that phosphorylation of domain I residues is critical for Pprotein function in transcription in vivo.
MATERIALS AND METHODS

FIG. 1. (A) Domain structure of the P protein of VSV (Indiana serotype).
The full-length P protein with the three functionally defined domains (I, II, and
III) and the hinge region is shown. The phosphate acceptor sites within the
domain I are shown by filled circles representing S-60 and S-64 and filled square
representing T-60. (B) Various mutant P proteins with alanine (A), glutamic acid
(E), phenylalanine (F), arginine (R), or threonine (T) substitutions at the phosphate-acceptor sites are shown.

form) which is transcriptionally inactive under in vitro transcription reconstitution conditions (3, 5). The bacterially expressed inactive P protein, however, becomes transcriptionally
active if it is first phosphorylated by casein kinase II (CKII) (4,
26). By various mutagenesis and biochemical studies, the acceptor sites for CKII-mediated phosphorylation of P protein
have been mapped to Ser-59 and Ser-61 for New Jersey serotype (51) and Ser-60, Thr-62, and Ser-64 for Indiana serotype
of VSV (13, 50). Phosphorylation of these residues which are
located in the amino-terminal acidic domain I of the protein
(see Fig. 1 for domain structure) has been recently shown to
mediate multimerization of the P protein that facilitates complex formation with the L protein (16, 24, 25). Although the
mechanism by which phosphorylation modulates the activities
of the P protein is not clear, it has been shown that such a
modification of New Jersey P protein substantially increases
the a-helical structures within the P protein (16), which may be
required for multimer formation and interaction with the L
protein.
Following phosphorylation of bacterially expressed P protein (P0 form) in domain I by CKII, the P1 protein undergoes
subsequent phosphorylation by L-associated kinase at two specific residues within domain II to generate P2 protein (4). It
has recently been shown that the P1 and P2 proteins of Indiana
serotype VSV are similar to the proteins previously designated
NS1 and NS2, respectively (13). There exists a precursor-product relationship between P1 and P2 forms, and P2 forms are
generated by phosphorylation of P1 at the two serine residues
(S-226 and S-227) within the domain II (13). In addition, it has
been shown recently that the P2 form can also be generated
directly from the P0 form by L-associated kinase or N-RNAassociated kinase by phosphorylation of residues in domain II
only (reference 13 and unpublished data from our laboratory).

Cell cultures and viruses. Baby hamster kidney (BHK-21) cells were grown as
monolayer cultures in Eagle’s minimal essential medium (MEM) containing
7.5% fetal bovine serum (FBS). Human 143B (thymidine kinase-negative) cells
were also grown in MEM supplemented with 5% FBS. VSV (Indiana serotype,
San Juan, and Mudd-Summers strains) were propagated in BHK-21 cells. Stocks
of DI-T particles (37) were prepared as described previously (46). Recombinant
vaccinia virus (vTF7-3) carrying the bacteriophage T7 RNA polymerase gene
(23) was propagated in BHK-21 cells by infecting the cells at a multiplicity of
infection of 0.1. Titers of stock vTF7-3 virus were determined by plaque assay in
143B cells.
Plasmids. Plasmids pN, pP, and pL, containing the coding sequences for the
VSV (Indiana serotype, San Juan strain) N, P, and L proteins under the control
of bacteriophage T7 RNA polymerase promoter in pGEM vectors (Promega
Biotech, Madison, Wis.), have been described previously (46). The construction
of the plasmid (pET-P) carrying a full-length cDNA clone of the P gene of VSV
(Indiana serotype, Mudd-Summers strain) in pET-3a vector and the construction
of various P-gene mutants used in the present study have been described recently
(13). Plasmid pDI, carrying a cDNA copy of the DI-T genomic RNA under the
control of T7 RNA polymerase promoter, has been described previously (45).
The construction of the plasmid, p9BN, used for in vivo transcription studies has
been described recently (39). Upon transcription by T7 RNA polymerase, p9BN
generates a positive-sense antigenomic VSV RNA [9BN(1)] 1,618 nt long. In
cells cotransfected with plasmids coding for VSV N, P, and L proteins and
9BN(1) RNA, the 9BN(1) RNA undergoes replication to generate the negative-sense genomic RNA [9BN(2)]. The 9BN(2) RNA is then transcribed by the
VSV polymerase to synthesize a chimeric mRNA (NDL mRNA) about 1,470 nt
long [excluding the poly(A) tail] containing the entire coding sequence of the N
gene and a part of the L gene.
Virus infections and DNA transfections. The procedures used are essentially
as described previously (46). Briefly, BHK-21 cells in 35-mm-diameter six-well
plates or in 60-mm-diameter plates were grown to approximately 90% confluency. Cells were then infected with the recombinant vaccinia virus (vTF7-3) at a
multiplicity of infection of 10. After adsorption at 37°C for 45 min, cells were
washed twice in serum-free Dulbecco’s modified MEM (DMEM) and subsequently transfected with various combinations of plasmids by using Lipofectin
(Gibco/BRL, Bethesda, Md.). Medium from the transfected cells was removed at
4 to 5 h posttransfection, cells were washed twice in DMEM supplemented with
2% FBS and incubated with appropriate volume of the same medium. For DI
particle infection to analyze DI RNA replication, washed cells at 4 to 5 h
posttransfection were superinfected with 500 ml of 1:500 dilution of stock DI
particles for 45 min at 37°C. Following adsorption, cells were washed twice in
serum-containing DMEM and incubated in 1.5 ml of the same medium containing [3H]uridine as described below. In most experiments, unless specifically
described in figure legends, 3 mg of pN, 3 mg of pET-P, 1 mg of pL, and 5 mg of
p9BN or pDI plasmids were used in transfection of cells in 60-mm-diameter
plates.
Metabolic labeling and analysis of proteins. To examine the expression of P
protein, cells transfected with pET-P plasmids were incubated in methioninefree DMEM at 18 h posttransfection for 45 min at 37°C and then labeled with 20
mCi of [35S]methionine per ml of the same medium for 2 h. In pulse-chase
experiments, after labeling with [35S]methionine, cell monolayers were washed
twice with medium containing a 100-fold molar excess of unlabeled methionine
and incubated for different lengths of time in the same medium containing
unlabeled methionine. Cell monolayers were then washed twice in cold phosphate-buffered saline, scraped into phosphate-buffered saline, and collected by
centrifugation in a microcentrifuge for 1 min at 4°C at 18,000 3 g. The cell pellets
were resuspended in radioimmunoprecipitation assay buffer, and cytoplasmic
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FIG. 2. SDS-PAGE analysis of wt and mutant P proteins expressed in transfected cells. BHK-21 cells in 35-mm-diameter wells of six-well plates were infected with vTF7-3 and subsequently transfected with 1.5 mg of each of the
plasmids indicated above the lanes. Transfected cells were labeled with [35S]methionine. Cell extracts were prepared; labeled P proteins were immunoprecipitated with anti-P (Indiana serotype, Mudd-Summers strain) antibody, separated
by SDS-PAGE, and detected by fluorography. Lanes 1 and 2 show the immunoprecipitated proteins from mock-infected and VSV (Mudd-Summers strain)infected cells, respectively. The P and N proteins in VSV-infected cells, which
form complexes, are often coimmunoprecipitated by either anti-N or anti-P
antibody and are seen as two intensely labeled and closely migrating protein
bands in lane 2.

extracts were prepared as before (46). P proteins were immunoprecipitated by
using a rabbit anti-P (Indiana serotype, Mudd-Summer strain) antibody, separated by polyacrylamide gel electrophoresis (PAGE) in 10% polyacrylamide gels
(33), and subsequently detected by fluorography (10).
In vivo labeling of RNA replication and transcription products and gel electrophoretic analysis. For DI RNA replication studies, transfected cells superinfected with DI particles were labeled with 25 mCi of [3H]uridine per ml overnight
(14 to 15 h). When replication was studied in pDI-transfected cells, cells at 16 to
18 h posttransfection were treated with 15 mg of actinomycin D per ml of DMEM
for 45 min at 37°C prior to labeling with [3H]uridine in the presence of actinomycin D for 6 h. After labeling, cytoplasmic extracts were prepared and nucleocapsids containing newly synthesized and labeled RNAs were immunoprecipitated with anti-VSV antibody as described earlier (46). The RNAs recovered
from immunoprecipitated nucleocapsids by phenol-chloroform extraction were
electrophoresed in an acid agarose-urea gel as described before (38, 46) and
detected by fluorography (35).
For transcription analysis, transfected cells at 14 to 16 h posttransfection were
treated with actinomycin D and labeled with [3H]uridine as described above.
Total RNAs from cytoplasmic extracts were recovered by extraction with phenol
and chloroform and analyzed by electrophoresis and fluorography as described
above. To determine the normalized levels of transcription supported by the
mutant P proteins, we took into consideration the relative levels of replication
and transcription supported by each mutant and the following formula: normalized levels of transcription 5 100 3 (relative levels of transcription/relative levels
of replication).

RESULTS
Expression and stability of wt and mutant P proteins in
transfected cells. Since the cDNAs encoding the wild-type (wt)
and mutant P proteins of VSV (Indiana serotype, Mudd-Summers strain) had been subcloned into pET-3a vector under the
control of the T7 RNA polymerase promoter (13), we first
wanted to determine the levels of expression of these proteins
in cells transfected with these plasmids. Accordingly, BHK-21
cells infected with vTF7-3 were transfected with plasmids encoding wt or mutant P proteins. Expression of P protein in
these cells was analyzed by metabolic labeling with [35S]methionine, immunoprecipitation with excess anti-P antibody to
quantitatively recover the expressed P proteins, and subsequent sodium dodecyl sulfate (SDS)-PAGE. Results (Fig. 2)
show that all of the mutant P proteins were expressed at levels
similar to that of the wt P protein. The levels of expressions
were comparable to the levels of expression of the P protein of

FIG. 3. (A) In vivo replication of DI RNA supported by the wt P or various
mutant P proteins. BHK-21 cells in 60-mm-diameter plates were infected with
vTF7-3 and subsequently transfected with pN, pL, and either wt P or mutant P
plasmids as described in Materials and Methods. After DI particle superinfection
and [3H]uridine labeling, cell extracts were prepared, nucleocapsids were immunoprecipitated, and the labeled RNAs recovered from the nucleocapsids were
analyzed by electrophoresis in an agarose-urea gel. 2 and 1 represent genomic
and antigenomic RNAs, respectively, of the DI particle. (B) Quantitative analysis
of relative levels of DI RNA replication supported by each of the mutant P
proteins. The histograms represent the average and the range of relative levels of
replication supported by various mutant P proteins. The data were obtained by
densitometric scanning of band intensities of the fluorogram shown in panel A
and those from two other similar experiments.

VSV (Indiana serotype, San Juan strain) under transfection
conditions similar to those described previously (46). From
pulse-chase experiments, we determined that more than 80%
of the wt and mutant P proteins were stable for at least 6 to 8 h
after synthesis (data not shown). Furthermore, we found that
in cotransfected cells, all of the viral proteins were expressed at
comparable levels (data not shown).
Replication of DI RNA in cells expressing mutant P proteins. Previous work from our laboratory showed that cells
expressing the N, P, and L proteins from transfected plasmids
support high levels of replication and amplification of DI RNA
(46). We used this system to determine the ability of the mutant P proteins to support DI RNA replication. BHK-21 cells
infected with vTF7-3 were transfected with plasmids encoding
the N, L, and wt or mutant P proteins. Following superinfection with DI particles, replication of DI RNA in these cells was
analyzed by [3H]uridine labeling, immunoprecipitation of labeled nucleocapsids, and agarose-urea gel electrophoresis of
RNAs recovered from the nucleocapsids. Results from a representative experiment is shown in Fig. 3A. All the mutant
proteins supported high levels of replication of DI RNA (lanes
3 to 9) compared to the wt protein (lane 2).
A quantitative analysis of the levels of replication of DI
RNA was performed by densitometric scanning of fluorograms
from three independent experiments and is shown in Fig. 3B.
The levels of DI RNA replication supported by the mutant P
proteins were at least 70% of that of the wt P protein. In some
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experiments, replication levels supported by the mutant P proteins were comparable to that of the wt P protein. From these
experiments, we conclude that phosphorylation of the residues
(S-60, T-62, and S-64) within the domain I of the P protein has
little or no effect on replication of DI RNA.
It should be noted that the foregoing experiments were
performed with the replicating DI RNA templates provided by
the superinfecting DI particles. When the experiments were
carried out with DI RNA provided by transfection of a plasmid
carrying a cDNA copy of DI RNA as previously described (45),
similar results were obtained (data not shown).
Analysis of the ability of mutant P proteins to support transcription in vivo. We next examined the ability of the mutant
P proteins to support transcription in vivo. To perform these
experiments, we used a plasmid (p9BN) containing a cDNA
fragment coding for a transcription- and replication-competent
VSV RNA template. The cDNA contained sequences from the
39 and 59 termini of the VSV genome, the entire N gene, and
a small part of the L gene (39). The RNA generated from the
cDNA by T7 RNA polymerase is a positive-sense antigenomic
RNA of VSV which must first be replicated to generate the
genomic RNA to be used as a template for transcription. In
initial experiments, we determined that the levels of replication
of the antigenomic RNA to generate the genomic RNA template correlated well with the levels of replication obtained
with DI RNA (data not shown) and thus provided the basis for
using plasmid p9BN to directly assess the effects of the mutations in P protein in in vivo transcription of VSV RNA.
To determine the effect of mutations in P protein on transcription, BHK-21 cells were infected with vTF7-3 and then
cotransfected with plasmids encoding the N, L, and wt or
mutant P proteins and plasmid p9BN. Transfected cells were
treated with actinomycin D at 16 h posttransfection to block
further synthesis of RNA from transfected DNA templates.
Transcription in these cells was then analyzed by examining the
synthesis of NDL mRNA in the presence of actinomycin D and
[3H]uridine. A fluorogram of total labeled RNAs synthesized
under these conditions and separated in an agarose-urea gel is
shown in Fig. 4A. Results show that the mutant P proteins
supported various levels of transcription relative to the wt P
protein. The level of transcription supported by P60 mutant
(lane 3) was about 40% of the wt P protein level (lane 2). The
other single-site substitution mutants (lanes 4 and 5) or the
double mutants (lanes 6 to 8), however, supported levels of
transcription that were about 3 to 10% of the wt P protein
level. The triple mutant in which all phosphate acceptor sites in
domain I have been substituted for alanines did not support
detectable levels of transcription (lane 9). Upon longer exposure of the fluorogram, we detected transcription products
whose levels were, on best estimation, 2 to 3% of that of the wt
P protein. This low level of transcription directed by the P60/
62/64 mutant was consistently observed in three independent
experiments. The levels of expression of the wt and mutant P
proteins in these experiments were comparable (similar to
those seen in Fig. 2); therefore, low levels of transcription
supported by the mutant proteins were not due to the levels of
expression of the mutant proteins.
A quantitative determination of the normalized levels of
transcription supported by the mutant P protein was performed. These data were obtained by taking into consideration
the relative levels of replication and transcription supported by
each mutant protein as described in Materials and Methods. It
should be noted that in these in vivo transcription experiments,
the plasmid used generates the antigenomic positive-sense
RNA of a VSV minigenome, which must first undergo replication to generate the negative-sense genomic RNA as the
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FIG. 4. (A) Analysis of in vivo transcription supported by various P mutants.
BHK-21 cells in 35-mm-diameter wells of six-well plates were infected with
vTF7-3 and then cotransfected with 1.5 mg of pN, 0.5 mg of pL, 2.5 mg of p9BN,
and 1.5 mg of pET-P plasmids coding for the wt or various mutant P proteins. At
14 to 16 h posttransfection, cells were treated with actinomycin D and labeled for
6 h with [3H]uridine. Total RNAs were extracted from cytoplasmic extracts and
analyzed by electrophoresis in an agarose-urea gel. NDL mRNA represents the
transcription product generated by VSV RNA polymerase in the transfected
cells under the experimental conditions used. (B) Quantitative determination of
the normalized levels of transcription. The data were obtained by scanning of the
band (NDL mRNA) intensities in the fluorogram shown in panel A and those
from two other similar experiments and taking into consideration of the relative
levels of replication and transcription as described in Materials and Methods.
The average and the range of normalized levels of transcription supported by
each mutant relative to the wt P protein are shown.

template for transcription. Thus, when the transcription activities of these mutants were calculated from the scanning of the
band intensities of the transcription product (NDL mRNA), we
also considered the relative levels of replication supported by
these mutant P proteins. The average normalized levels of
transcription supported by these mutants determined in this
manner are shown in Fig. 4B. These results show that mutations in the phosphate acceptor sites within the domain I of the
P protein severely impair its ability to function efficiently in
transcription in vivo. Phosphorylation of T-62 and S-64 residues appear to be more critical than that of the S-60 residue in
transcription. Taken together, these data strongly suggest that
phosphorylation within domain I is important for transcription
activity of the P protein.
Increasing amounts of P60/62/64 expression do not rescue
transcription in vivo. Data from Fig. 4 show that relative levels
of transcription supported by most of the mutant P proteins
(except P60) were very low compared to the wt P protein level.
In these experiments, a fixed amount of plasmid encoding wt or
mutant P proteins was used in transfection. Our earlier results
(shown in Fig. 2) suggested that comparable amounts of P
proteins were being synthesized in transfected cells under
these conditions and that the P proteins remained stable for at
least 6 to 8 h after synthesis. Therefore, the low levels of
transcription supported by these mutant P proteins were not
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FIG. 5. (A) In vivo transcription supported by various amounts of P60/62/64
protein. Transcription analysis was performed as described in the legend to Fig.
4A, but various amounts (micrograms) of P60/62/64 plasmid DNA (as shown above
the lanes) were used in transfection. The arrow indicates the product (NDL
mRNA) of transcription. (B) Transcription supported by various amounts of
P60/64. The experiment was performed as described for panel A with the indicated amounts (micrograms) of P60/64 plasmid used in transfection.

due to their relative instability. It is possible that the mutant
proteins assume different structural conformations (as a result
of loss of some or all of the phosphorylation sites in domain I)
that are not competent to support efficient transcription. Alternatively, these mutant proteins may have lost the ability to
efficiently oligomerize and/or interact with the L protein, which
may depend on the concentration or the amount of the mutant
protein in transfected cells. Therefore, it may be possible to
rescue transcription by expressing increasing or decreasing
amounts of mutant P proteins in transfected cells.
To address such a possibility, we chose to use P60/62/64, since
transcription with this mutant was most severely impaired.
Results shown in Fig. 5A suggest that decreasing the amount of
P60/62/64 protein expression (by decreasing the amount of
P60/62/64 plasmid during transfection) resulted in almost undetectable levels of transcription (lanes 3 and 4). When the
P60/62/64 expression was increased, the level of transcription
gradually increased (lanes 6 to 8). With 6 mg of transfected
P60/62/64 plasmid (lane 8), the level of transcription was 7 to 8%
of the level of transcription supported by 1.5 mg of transfected
wt P plasmid (lane 1). Further increase in the amount of
P60/62/64 plasmid in transfection did not result in increased
levels of transcription (data not shown). It should noted that
with increasing amounts of the plasmid transfected (up to 9
mg), a corresponding increase in the P-protein expression was
observed (data not shown), which is consistent with our previous observation (46) and those obtained recently by Spadafora
et al. (50).
It has been observed recently that the P mutant (P60/64) with
alanine substitution at residues 60 and 64 in domain I, when
expressed in vivo, does not contain phosphorylated T-62 and is
not phosphorylated (13, 30). This result was interpreted to
suggest that phosphorylation of T-62 is dependent on prior
phosphorylation of S-64 (30). However, under in vitro phosphorylation conditions, the mutant protein could be readily
phosphorylated at T-62, which led to the suggestion that the
mutant protein is phosphorylated at T-62 when expressed in
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vivo but perhaps is selectively dephosphorylated by the phosphatase(s) present in the cell extracts (13). When this mutant
protein was tested for its ability to support transcription under
in vitro conditions, it was found to be much less active (#5%
of the wt P level) at low concentrations but was active (about
28% of the wt P level) at higher concentrations of the P protein
(50). We therefore wished to determine if this mutant protein
could rescue transcription in vivo with increased concentrations of the protein. Accordingly, in vivo transcription activity
of the mutant protein was analyzed in cells expressing various
amounts of the protein. Results in Fig. 5B show that a slight
increase in transcription in vivo with increasing amounts of
P60/64 was observed. However, the level of transcription (8 to
10%) was significantly below that obtained with wt P protein.
Taken together, results shown in Fig. 5 suggest that increasing
amounts of the mutant P proteins (P60/64 and P60/62/64) do not
rescue their in vivo transcription activities.
Replication and transcription supported by mutant P proteins substituted with other amino acids. Results in Fig. 3 to 5
show that mutant proteins with alanine substitutions at the
three phosphate acceptor sites (S-60, T-62, and S-64) in domain I can support high levels of replication in vivo whereas
transcription activity in vivo of these mutants is severely impaired. It is possible that these alanine substitutions induce a
conformation in the mutant protein that has no effect on the
replicative function of the protein but may not be compatible
for its transcription function. To determine whether other
amino acid substitutions at these three sites allow for generation of functional P proteins, we generated a set of mutant P
proteins with substitution of a number of different amino acids:
PEEE, containing glutamic acid (negatively charged residue);
PFFF, containing phenylalanine (hydrophobic residue with an
aromatic ring); PRRR, containing arginine (positively charged
residue); and PTTT, containing threonine (polar residue similar
to serine).
The ability of each of these mutant P proteins to support
replication of DI RNA was analyzed as described above. Results of such an analysis (Fig. 6A) show that the mutant proteins supported DI RNA replication to various degrees. Replication supported by PEEE and PFFF (lanes 4 and 5) was
approximately 40% of that of the wt P protein (lane 2). PTTT
mutant supported replication (lane 7) at a level similar to that
for P60/62/64 mutant (lane 3), which was approximately 75% of
the wt P protein level. The level of replication supported by
PRRR mutant (lane 6) was significantly below the wt level.
Upon longer exposure of the gel, it was possible to detect
replication products, which represented approximately 5% of
the level of replication supported by the wt P protein. Increasing amounts of PRRR did not increase the level of replication
of DI RNA significantly (data not shown). Thus, these results
show that the P protein with other amino acid (except arginine) substitutions at positions 60, 62, and 64 can still function
relatively well in supporting RNA replication in vivo.
We next examined the ability of these mutant proteins to
support transcription in vivo. Transcription activity of these
mutant P proteins was analyzed as described before. Results of
this experiment are shown in Fig. 6B. PEEE (lane 4) and PTTT
(lane 7) proteins supported significantly high levels of transcription, whereas transcription activity of PFFF and PRRR mutants was at a level below detection (lanes 5 and 6). Upon
longer exposure of the fluorogram, it was still not possible to
detect transcription products supported by these mutants. A
quantitative measurement of the relative levels of replication
and normalized levels of transcription supported by these mutants was performed from the data shown in Fig. 6A and B and
from two other similar experiments, using the formula as de-
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FIG. 6. Replication and transcription supported by mutant P proteins substituted for other amino acids. (A) Replication assay performed as described for
Fig. 3A with the mutant P proteins indicated above the lanes. (B) Transcription
analysis with the indicated mutants, using the assay described for Fig. 4A. (C)
Quantitative determination of the levels of replication and normalized levels of
transcription supported by the mutants. The relative level of replication supported by each of the mutants was obtained by taking the average of the scanning
data from three separate experiments. The normalized level of transcription
supported by the mutants was also obtained by taking the average of the scanning
data from three separate experiments and taking into consideration the relative
level of replication and transcription supported by each mutant as described in
Materials and Methods.

scribed in Materials and Methods. The results are shown in
Fig. 6C. We determined that the PEEE and PTTT mutants were
almost (86 and 113%, respectively) as active as the wt P protein
in transcription in vivo. It should be noted that the PTTT mutant is phosphorylated in vitro by recombinant CKII as well as
by the CKII purified from BHK cells. The phosphate-to-protein ratio for PTTT is similar to that of the wt P protein (data
not shown), indicating that the threonine residues in PTTT are
phosphorylated. The level of transcription supported by PFFF
and PRRR could not be determined definitely in the absence of
any detectable transcription products even upon very long exposure of the gel. Since PFFF supports replication at a level
similar to that for PEEE, transcription at a level of $5% could
have been detected for this mutant. Although PRRR supports
replication only to 5 to 6% of the wt level, transcription at a
level $5% of the wt level also could have been detected for this
mutant. From these results, we estimate that both PFFF and
PRRR support transcription at a level ,5% of the wt P protein
level.
From these experiments, we conclude that while substitution
with glutamic acid or threonine residues at the phosphate
acceptor sites in domain I of the P protein does not affect the
in vivo transcription activity of the P protein, substitution of
phenylalanine, arginine, or alanine residues at these sites renders the protein significantly inactive in transcription.
Mutant P proteins do not act as transdominant repressors
of transcription or replication. Since some of the mutant P
proteins are found to be significantly defective in supporting
replication and/or transcription, we wished to determine
whether these mutant P proteins, when coexpressed along with
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FIG. 7. Effect of coexpression of wt P protein and mutant P proteins on
replication and transcription. (A) For replication assay, various amounts (micrograms) of plasmid encoding wt P or mutant PRRR (as indicated above the lanes)
were transfected either individually or together, and DI RNA replication in these
transfected cells was analyzed as described for Fig. 3A. 2 and 1 represent
genomic and antigenomic DI RNAs. (B) For transcription analysis, various
amounts (micrograms) of plasmids encoding wt P or P60/62/64 were transfected
either individually or together, and transcription of NDL mRNA (indicated by
the arrow) in these cells was studied as described for Fig. 4A.

the wt P protein, will interfere with the normal functioning of
the wt P protein and therefore act as transdominant repressors.
For these studies, we chose PRRR, which supports replication
at approximately 5% of the wt P protein, and P60/62/64, which
supports transcription at about 2 to 3% of the wt level.
To examine whether PRRR acts as a transdominant repressor
in replication supported by the wt P protein, replication of DI
RNA in cells coexpressing both PRRR and the wt P protein was
analyzed. Results shown in Fig. 7A demonstrate that PRRR
protein alone supports very low levels of replication (lanes 3
and 6), further confirming the results shown in Fig. 6A. However, when PRRR is coexpressed along with the wt P protein,
the level of replication supported by the wt P protein was not
decreased (lanes 4, 5, 7, and 8). Furthermore, increasing PRRR
expression by increasing the amount of the plasmid in transfection did not result in any measurable inhibition of RNA
replication supported by the wt P protein. These results, therefore, indicate that the PRRR protein does not act as a transdominant repressor to inhibit the function of the wt P protein
in replication in vivo.
To determine whether P60/62/64 acts as a transdominant repressor of transcription in vivo supported by the wt P protein,
we analyzed transcription in cells coexpressing the P60/62/64 and
the wt P proteins. Results of this experiment are shown in Fig.
7B. As can be seen from this figure, very low levels of transcription was observed for P60/62/64 (lane 4). The level of transcription supported by a constant amount of the wt P protein
in the presence of increasing amounts of P60/62/64 (lanes 5 to 8)
was comparable to the level of transcription supported by the
same amount of the wt P protein alone (lane 1). The inability
of P60/62/64 protein to inhibit transcription in vivo supported by
the wt P protein demonstrates that the mutant P protein does
not act as a transdominant repressor of transcription in vivo.

VOL. 71, 1997

ROLE OF P PROTEIN PHOSPHORYLATION IN VSV RNA SYNTHESIS

DISCUSSION
The phosphoprotein P of VSV is a multifunctional protein.
It is an essential component of the viral RNA polymerase
complex (P-L) and is thought to mediate the interaction of the
L protein with the viral nucleocapsid template for transcription
and replication. It also interacts with the N protein to form N-P
complexes that are required for encapsidation of nascent RNA
chain during replication (34, 47). In virus-infected cells as well
as in the virion core, the P protein has been shown to exist in
multiple phosphorylated forms (7, 14, 27, 28, 32, 41). In this
study, we examined the role of phosphorylation within the
amino-terminal acidic domain I of the P protein of VSV (Indiana serotype) in transcription and replication under in vivo
conditions. Using a panel of mutant P proteins in which the
phosphate acceptor sites were replaced with alanines or other
amino acids either individually or in combination, we analyzed
the ability of each of the mutant proteins to support replication
of DI RNA in vivo and transcription of VSV mRNA in vivo.
From the results documented here, we conclude that although
phosphorylation of P protein in the domain I residues is not
essential for replication function of the protein, this modification is critical for its transcriptional activity. Using a similar
panel of mutant P proteins, Spadafora et al. recently concluded
that phosphorylation of the domain I residues of the Indiana
serotype P protein does not play a major role in DI RNA
replication in vivo (50). Our results presented in this report
confirm their results of in vivo DI RNA replication studies.
Over the last several years, we and others have been studying
the role of phosphorylation of P protein, using in vitro transcription reconstitution systems. The conclusions drawn from
these studies have been somewhat conflicting. Recent studies
suggest that phosphorylation of residues within the domain I of
the P protein of Indiana serotype by CKII is essential for its in
vitro transcription function (24–26). However, recently it was
also shown that phosphorylation per se is not essential for
transcription in vitro, and the authors proposed that such a
modification may enable the protein to efficiently multimerize
and interact with the L protein (50). These conclusions were
based on the observation that the double mutant S60A/S64A
(same as the P60/64 mutant in our study) could rescue transcription to about 28% of the wt P protein at high concentrations. Under the in vivo transcription conditions used here,
however, we were unable to detect significant levels of transcription in assays using either P60/62/64 or P60/64 (Fig. 4 and 5).
The inherent difference between the in vivo transcription assay
used by us and the in vitro reconstitution assay used by
Spadafora et al. (50) may explain the discrepancy in the results
of these studies. It is possible that the S60A/S64A mutant does
not result in a completely nonphosphorylated form of the protein. Although it was suggested that the T-62 residue is not
phosphorylated in this mutant (30, 50), phosphorylation and
subsequent dephosphorylation of this residue could not be
ruled out. In fact, this may appear to be the case, since we have
recently shown that this mutant can be phosphorylated in vitro
(13). It is noteworthy that recently we have expressed L protein
and the mutant P proteins either separately or together in COS
cells by using a simian virus 40-based vector and have carried
out transcription reconstitution in vitro with the cell extracts
(41a). The results from these studies indicate that P60/62/64
mutant is barely (5 to 10%) active in supporting transcription,
confirming our in vivo transcription results presented here.
Thus, phosphorylation within domain I seems to be important
for transcription function of the P protein.
Regardless of the type of transcription system used, it is
clear from several studies that multimerization of P protein is
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critical for its transcriptional activation (16, 24, 25). The multimerization of P has been shown to be absolutely required for
interaction with the L protein as well as the N-RNA template.
Furthermore, phosphorylation of domain I residues by CKII
has been shown to be required for self-association of P into
multimeric structures (16, 24, 25). Therefore, based on these
results, it has been proposed that transcriptional activation of
P protein occurs as a result of phosphorylation by CKII leading
to multimerization and interaction with the L protein. It is
possible that under the in vitro transcription conditions (50),
the S60A/S64A mutant protein without phosphorylation assumes a conformation that favors low levels of multimer formation to support the observed level (28%) of transcription.
However, we tend to favor the view that in a more relevant in
vivo transcription condition used in our experiments, the unphosphorylated protein assumes a conformation unfavorable
for multimer formation and therefore is transcriptionally inactive. The mechanism by which phosphorylation leads to multimerization is not known; however, phosphorylation of domain I residues by CKII has been shown to significantly
increase the a-helical content of the P protein of New Jersey
serotype VSV (16). Whether the increased a-helical content of
the protein leads to a conformation favorable for multimerization or not remains to be determined.
It is interesting that the phosphate acceptor sites in domain
I reside in a region that contains a large number of acidic
residues (58 DDSDTESEPE 67). Phosphorylation of S and T
residues (shown in boldface) may increase the net negative
charge within this region such that the protein can assume a
conformation compatible for multimerization and subsequent
transcriptional activation. Indeed, substitution of S and T residues with aspartic acid (negatively charged) residues results in
a protein that multimerizes and functions well in transcription
(25), whereas substitution with alanine leads to a protein that
does not multimerize and remains transcriptionally inactive
(24, 25). Our results (Fig. 6) provide further credence to this
hypothesis. Substitution with a different negatively charged
residue (glutamic acid) resulted in a protein that was almost
(86%) as active as the wt protein, whereas substitution with a
positively charged residue (arginine) led to a transcriptionally
inactive (,5%) protein. Furthermore, substitution with threonine (which is phosphorylated by CKII [data not shown]) also
led to a protein that was at least as active (113%) as the wt
protein in transcription. From these results, it appears that
increase in net negative charge in this region of the protein as
a result of phosphorylation is crucial for its transcriptional
activation.
The observation that multimerization of P protein mediated
by phosphorylation within domain I is required for interaction
with L protein and subsequent transcriptional activation
whereas the nonphosphorylated form of the protein cannot
multimerize but can function as well as its phosphorylated
counterpart in replication raises one interesting possibility as
to the molecular structure of the transcriptase and the replicase of the virus. Since the L protein must interact with the P
protein to carry out these functions, we propose (Fig. 8) that
the monomeric form of a subset of P protein (P0 or P2), by
interacting with L protein directly or indirectly, forms a complex that functions as a replicase. An association with the
soluble N-P complex may be important for the replicase to
function. On the other hand, the L protein, by interacting with
a phosphorylation-dependent multimer of P1 protein, forms a
complex that functions efficiently as a transcriptase (Fig. 8).
The composition of the P multimer is uncertain; however,
dimeric structures of P New Jersey serotype (16) and probably
tetrameric structures of P Indiana serotype (25) have been
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and inhibits the activity of the wt P protein in an in vitro
transcription reconstitution system (16). It will be interesting
to find out whether other mutant P proteins act as transdominant repressors.
In summary, our results suggest that phosphorylation within
the amino-terminal acidic domain I of the P protein appears to
be critical for the transcription function of the protein whereas
such a modification is not necessary for its replication function.
Based on these results, we propose that the L protein of VSV
manifests its transcriptase and replicase activities by complexing with differentially phosphorylated forms of the P protein.
With the availability of infectious molecular clones of VSV (36,
55), it will be interesting to analyze the effects of these mutations in P protein in transcription and replication in the context
of infectious VSV.
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